These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34653727)

  • 1. Carnosine alleviates podocyte injury in diabetic nephropathy by targeting caspase-1-mediated pyroptosis.
    Zhu W; Li YY; Zeng HX; Liu XQ; Sun YT; Jiang L; Xia LL; Wu YG
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108236. PubMed ID: 34653727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
    Cheng Q; Pan J; Zhou ZL; Yin F; Xie HY; Chen PP; Li JY; Zheng PQ; Zhou L; Zhang W; Liu J; Lu LM
    Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
    Gao Y; Ma Y; Xie D; Jiang H
    Int Immunopharmacol; 2022 Jun; 107():108711. PubMed ID: 35338958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis.
    Liu XQ; Jiang L; Lei L; Nie ZY; Zhu W; Wang S; Zeng HX; Zhang SQ; Zhang Q; Yard B; Wu YG
    Clin Sci (Lond); 2020 Dec; 134(23):3175-3193. PubMed ID: 33241846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20.
    Ding X; Jing N; Shen A; Guo F; Song Y; Pan M; Ma X; Zhao L; Zhang H; Wu L; Qin G; Zhao Y
    J Endocrinol Invest; 2021 Jun; 44(6):1175-1184. PubMed ID: 32930981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.
    Sun L; Ding M; Chen F; Zhu D; Xie X
    PeerJ; 2023; 11():e14826. PubMed ID: 36815984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VX-765 ameliorates renal injury and fibrosis in diabetes by regulating caspase-1-mediated pyroptosis and inflammation.
    Wen S; Deng F; Li L; Xu L; Li X; Fan Q
    J Diabetes Investig; 2022 Jan; 13(1):22-33. PubMed ID: 34494385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
    Lv C; Cheng T; Zhang B; Sun K; Lu K
    Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
    [No Abstract]   [Full Text] [Related]  

  • 9. Microencapsulated islet transplantation alleviates podocyte injury in diabetic nephropathy via inhibiting Notch-1 signaling.
    Yuan J; Lin F; Chen L; Huang H; Ni X; Pan X; Chen B; Cai Y
    Transpl Immunol; 2022 Jun; 72():101579. PubMed ID: 35278650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
    Gao J; Liang Z; Zhao F; Liu X; Ma N
    Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
    Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
    Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
    Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
    Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Punicalagin Protects Diabetic Nephropathy by Inhibiting Pyroptosis Based on TXNIP/NLRP3 Pathway.
    An X; Zhang Y; Cao Y; Chen J; Qin H; Yang L
    Nutrients; 2020 May; 12(5):. PubMed ID: 32456088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
    Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
    Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation.
    Zhang Q; Hu Y; Hu JE; Zhang M
    Drug Dev Res; 2022 Nov; 83(7):1697-1706. PubMed ID: 36048966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells.
    Qu X; Zhai B; Liu Y; Chen Y; Xie Z; Wang Q; Wu Y; Liu Z; Chen J; Mei S; Wu J; You Z; Yu Y; Wang Y
    Biomed Pharmacother; 2022 Jun; 150():112998. PubMed ID: 35489281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penehyclidine hydrochloride suppresses inflammation response and reduces podocyte injury in diabetic nephropathy by targeting fibrinogen-like protein 2.
    Tan HB; Zhao Q; Chen L
    Int Immunopharmacol; 2022 Jun; 107():108680. PubMed ID: 35303505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway.
    Li F; Chen Y; Li Y; Huang M; Zhao W
    Eur J Pharmacol; 2020 Nov; 886():173449. PubMed ID: 32758570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF-kB/NLRP3 inflammasome pathway.
    Xu X; Qin Z; Zhang C; Mi X; Zhang C; Zhou F; Wang J; Zhang L; Hua F
    Cell Biol Int; 2023 Jun; 47(6):1126-1135. PubMed ID: 36841942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.